Contribution of small airway inflammation to the development of COPD
Open Access
- 5 March 2024
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 24 (1) , 1-10
Abstract
Background: Little attention has been paid to the pathophysiological changes in the natural history of chronic obstructive pulmonary disease (COPD). The destructions of the small airways were visualized on thoracic micro-computed tomography scan. We investigated whether small airway inflammation (SAI) was the risk for the development of COPD. Methods: A total of 1062 patients were enrolled and analyzed in the study. The partitioned airway inflammation was determined by exhaled nitric oxide (NO) of FnNO, FeNO50, FeNO200, and calculated CaNOdual. Both FeNO200 and CaNOdual were compared to detect the promising predictor for peripheral airway/alveolar inflammation in COPD. The correlation between exhaled NO and white cell classification was evaluated to determine the inflammation type during the development of COPD. Results: Exhaled NO levels (FnNO, FeNO50, FeNO200, and CaNOdual) were the highest in the COPD group compared with all other groups. Furthermore, compared with controls, exhaled NO levels (FeNO50, FeNO200, and CaNOdual) were also significantly higher in the emphysema, chronic bronchitis, and smoking groups. FeNO200 was found to be a promising predictor for peripheral airway/alveolar inflammation (area under the curve [AUC] of the receiver operating characteristic [ROC] curve, area under the curve [AUC] = 0.841) compared with CaNOdual (AUC ROC = 0.707) in COPD. FeNO200 was the main risk factor (adjusted odds ratio, 2.191; 95% CI, 1.797–2.671; p = 0.002) for the development of COPD. The blood eosinophil and basophil levels were correlated with FeNO50 and FeNO200. Conclusion: The complete airway inflammations were shown in COPD, whereas SAI was the main risk factor for the development of COPD, which might relate to eosinophil and basophil levels.Keywords
Funding Information
- National Key R&D Plan (2020YFC2003700)
- Shanghai Municipal Key Clinical Specialty (shslczdzk02201)
- the Construction of Multidisciplinary Cooperative Diagnosis and Treatment for Severe Pneumonia (W2020-013)
- the Mechanisms of Antibiotic Resistance in Severe Pneumonia Treated with Traditional Chinese and Western Medicine (Number: ZY (2021-2023)-0207-01)
- Science and Technology Commission of Shanghai Municipality (20DZ2261200)
This publication has 41 references indexed in Scilit:
- An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practiceRespiratory Investigation, 2021
- Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional studyThe Lancet Respiratory Medicine, 2018
- Chronic obstructive pulmonary diseaseNature Reviews Disease Primers, 2015
- Early chronic obstructive pulmonary disease: definition, assessment, and preventionThe Lancet, 2015
- Current evidence and future research needs for FeNO measurement in respiratory diseasesRespiratory Medicine, 2014
- Nitrative stress in inflammatory lung diseasesNitric Oxide, 2011
- Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled studyThe Lancet, 2008
- Immunology of asthma and chronic obstructive pulmonary diseaseNature Reviews Immunology, 2008
- Pathophysiology of airflow limitation in chronic obstructive pulmonary diseaseThe Lancet, 2004
- Site and Nature of Airway Obstruction in Chronic Obstructive Lung DiseaseNew England Journal of Medicine, 1968